Next, we analyzed the gene expression profiles for IRF4 expression in different types of B cell lymphomas with a total of 336 samples which include 36 cancer cell lines (10.7%), 125 experimentally manipulated B cell lines (37.2%), and 25 normal B cell samples (7.4%) [41]. This evidence concerns the gene IRF4 and B-cell non-Hodgkin lymphoma.